My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
18 Jan 2013 | 02:08 GMT | Posted by Helen Shen | In the first study of its kind, the US Centers for Disease Control and Prevention (CDC) unveiled statistics…
Contact: Carole Bartoo carole.bartoo@vanderbilt.edu 615-322-4747 Vanderbilt University Medical Center UNC, Vanderbilt discover a new live vaccine approach for SARS and novel coronaviruses Rapid mutation has long been considered a key…
6:13pm EDT By Kate Kelland LONDON (Reuters) - A new virus belonging to the same family as the SARS virus that killed 800 people in 2002 has been identified in…
Public release date: 20-May-2009 - mice treated with the protein, Griffithsin (GRFT), had a 100 percent survival rate after exposure to the SARS coronavirus (SARS-CoV), as compared to a 30…
You must be logged in to post a comment.